Donate

Publication Details

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Zoledronic acid for primary breast cancer

Zoledronic acid for primary breast cancer (April 2019)

Zoledronic acid is a drug that’s given to reduce the risk of breast cancer spreading to the bones and other parts of the body. This booklet explains what it is, who might be offered it and the side effects it can cause.

Author(s)
Breast Cancer Care
Place of publication
London
Publisher
Breast Cancer Care
Date of publication
April 2019
Pages
12pp
Edition
1st edition
Order reference
Supplier
https://breastcancernow.org/
Subject(s)
Breast cancer, Bisphosphonates, Zoledronic acid
Format
Booklet
Language
English
Flesch readability score
65.6
Download this resource
Download this resource
Back to results
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Donate

About this site

Macmillan sites

Right there with you

We're here to provide physical, financial and emotional support. So whatever cancer throws your way, we're right there with you. Contact us

Follow us

© Macmillan Cancer Support 2019 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 89 Albert Embankment, London SE1 7UQ. VAT no: 668265007